SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at [email protected]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JinkoSolar Holding Co., Ltd. – JKS
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-99
Cunard brings star power to Miami
Broadway legend Sutton Foster performs onboard Cunard’s newest ship, Queen Anne ahead of her engagement during Queen Elizabeth’s 2025-2026 Miami homeporting VALENCIA, Calif., Jan. 21, 2025 /PRNewswire/ — History was made today when Cunard celebrated Queen Anne’s arrival in
Unigel disclose additional information
SÃO PAULO, Jan. 21, 2025 /PRNewswire/ — Unigel Participações S.A. and some of its subsidiaries (“Company“, “Unigel“) announce that, in connection with the extrajudicial reorganization process, Unigel engaged in confidential discussions and negotiations under confide
Canadian Investment Regulatory Organization Trade Resumption – ABR
VANCOUVER, BC, Jan. 21, 2025 /CNW/ – Trading resumes in: Company: Arbor Metals Corp. TSX-Venture Symbol: ABR All Issues: Yes Resumption (ET): 8:00 am 1/22/2025 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts
Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer
SAN DIEGO, Jan. 21, 2025 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced preliminary efficacy and safety d
Galaxy Asset Management: December 2024 Month End AUM
NEW YORK, Jan. 21, 2025 /CNW/ – Galaxy Digital Holdings Ltd. (TSX: GLXY) (“Galaxy”) announced that its affiliate, Galaxy Asset Management, (“GAM”), reported preliminary assets under management of $5.7 billion as of December 31, 2024. The 6.5% decrease in preliminary AU
Marriott International Announces Release Date For Fourth Quarter 2024 Earnings
BETHESDA, Md., Jan. 21, 2025 /PRNewswire/ — Marriott International, Inc. (Nasdaq: MAR) will report fourth quarter 2024 earnings results on Tuesday, February 11, 2025, at approximately 7:00 a.m. Eastern Time (ET). The company will hold a conference call for the investment community on Tuesday
USNDA Forms Inter-Service U.S. Military Competitive Drone Teams, U.S. Marines First to Fight in International Military Drone Crucible Championship on Independence Day Week
WASHINGTON, Jan. 21, 2025 /PRNewswire/ — Today, the USNDA announced its sponsorship of the first interservice, international U.S. Military Drone Crucible Championship (MDCC), to measure, incentivize and rapidly integrate small drone skills and capabilities across the armed services. The MD
Karmanos Cancer Institute Opens 17th Clinic in Dearborn
Karmanos Cancer Institute – Dearborn offers oncology care for many types of cancer, cancer screening and prevention DETROIT, Jan. 21, 2025 /PRNewswire/ — Today, the Barbara Ann Karmanos Cancer Institute, part of McLaren Health Care, cut the ribbon at the new Karmanos Cancer Institute – De
